A New Treatment for Portal Hypertension?

Slides:



Advertisements
Similar presentations
Hepatic Vascular Endothelial Growth Factor Regulates Recruitment of Rat Liver Sinusoidal Endothelial Cell Progenitor Cells Lin Wang, Xiangdong Wang, Lei.
Advertisements

Don C. Rockey  Clinical Gastroenterology and Hepatology 
Abhishek Chauhan, David H. Adams  Gastroenterology 
Byeong–Moo Kim, Michael Y. Choi  Gastroenterology 
Don C. Rockey  Clinical Gastroenterology and Hepatology 
Evaluation and Management of End-Stage Liver Disease in Children
Cost-Effectiveness of Access Expansion to Treatment of Hepatitis C Virus Infection Through Primary Care Providers  Thilo Rattay, Ian P. Dumont, Hauke.
Volume 144, Issue 5, Pages (May 2013)
Genetics and Genomics in the Practice of Medicine
Effectiveness of Hepatitis B Treatment in Clinical Practice
Is HCV Infection a Neurologic Disorder?
Outcomes Among Living Liver Donors
Daniel A. Langer, Vijay H. Shah  Journal of Hepatology 
Lost in Inflammation: The Functional Conversion of Regulatory T Cells in Acute Hepatitis A Virus Infection  Tobias Boettler, Robert Thimme  Gastroenterology 
Unusual Cause of Elevated Liver Enzymes in a Female Patient
How to Critically Read the GI Epidemiology Literature
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Mechanisms of Hepatic Fibrogenesis
Making Sense of HDAC2 Mutations in Colon Cancer
From Embryonic Stem Cells to β-Cells: New Hope for Diabetics?
DLC1 and Liver Cancer: The Akt Connection
Volume 155, Issue 4, Pages (October 2018)
Volume 134, Issue 5, Pages (May 2008)
Clinical Challenges and Images in GI
The Changing Liver Transplant Waitlist: An Emerging Liver Purgatory?
Volume 135, Issue 4, Pages (October 2008)
Inflammation and portal hypertension – The undiscovered country
A Historical Perspective on Clinical Advances in Pancreatic Diseases
Volume 150, Issue 4, Pages (April 2016)
The Bone Marrow and Liver Fibrosis: Friend or Foe?
Jean-Michel Pawlotsky  Gastroenterology 
Liver Sinusoidal Endothelial Cells: An Antiviral “Defendothelium”
A. Sidney Barritt, Michael W. Fried  Gastroenterology 
Hepatitis C and Hepatocellular Carcinoma: Grist for the Mill
Colon Cancer: An Update and Future Directions
Volume 137, Issue 1, Pages (July 2009)
Volume 146, Issue 5, Pages (May 2014)
Singling Out Intestinal Epithelial Stem Cells
Michael J. Williams, Andrew D. Clouston, Stuart J. Forbes 
Carbon Monoxide, Hydrogen Sulfide, and Nitric Oxide as Signaling Molecules in the Gastrointestinal Tract  Gianrico Farrugia, Joseph H. Szurszewski  Gastroenterology 
Volume 153, Issue 5, Pages (November 2017)
Covering the Cover Gastroenterology
YAPping About Glutaminolysis in Hepatic Fibrosis
Efficient Early Drug Development for Ulcerative Colitis
Coffee and Colorectal Cancer: Grounds for Prevention?
Reduced Mortality Rates Following Elective Percutaneous Liver Biopsies
Volume 132, Issue 2, Pages (February 2007)
Volume 133, Issue 2, Pages (August 2007)
Volume 150, Issue 7, Pages (June 2016)
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Volume 148, Issue 3, Pages (March 2015)
Jeremy P. Dwyer, Patrick Hosking, John Lubel  Gastroenterology 
Volume 150, Issue 7, Pages (June 2016)
Manuel Romero-Gómez, Javier Ampuero  Gastroenterology 
Statin Therapy Improves Sustained Virologic Response Among Diabetic Patients With Chronic Hepatitis C  Gowtham A. Rao, Prashant K. Pandya  Gastroenterology 
The Dawning of a New Editorial Board for Gastroenterology
Volume 132, Issue 5, Pages (May 2007)
Changing of the Guards: 2011–2016 Gastroenterology Team
Volume 134, Issue 1, Pages 8-14 (January 2008)
Statins: Old drugs as new therapy for liver diseases?
Volume 156, Issue 3, Pages (February 2019)
Volume 155, Issue 6, Pages (December 2018)
Volume 138, Issue 6, Pages (May 2010)
End-Stage Liver Disease in 2008: Finally a Glass Half Full
Reinvesting in US Biomedical Research—The Time is Now
Electronic Clinical Challenges and Images in GI
Neil D. Theise, Reichiro Kuwahara  Gastroenterology 
Controversies in Liver Transplantation for Hepatitis C
Volume 142, Issue 7, Pages (June 2012)
A Rare Tumor of the Liver With a Sudden Presentation
Presentation transcript:

A New Treatment for Portal Hypertension? Don C. Rockey  Gastroenterology  Volume 150, Issue 5, Pages 1077-1080 (May 2016) DOI: 10.1053/j.gastro.2016.03.015 Copyright © 2016 AGA Institute Terms and Conditions

Figure 1 Cell and molecular mechanisms of statins. Statins have pleotropic molecular effects. In sinusoidal endothelial cells, they seem to directly affect the eNOS signaling pathway. They activate Akt, which in turn leads to activation of endothelial nitric oxide (NO) synthase (eNOS), resulting in NO production and intrahepatic vasodilation. Statins also seem to have effects on hepatic stellate cells, interrupting a number of signaling cascades, some of which may be involved in their activation, fibrogenesis and/or contractility. There also is the potential for downstream paracrine effects of statins on either sinusoidal endothelial cells or hepatic stellate cells as highlighted by the arrows. Currently available evidence suggests cross talk each way. Together, available data suggest that statins have beneficial effects on both sinusoidal endothelial cells and hepatic stellate cells within the liver. Gastroenterology 2016 150, 1077-1080DOI: (10.1053/j.gastro.2016.03.015) Copyright © 2016 AGA Institute Terms and Conditions